Knownwell
Knownwell is a hybrid obesity medicine clinic operating in select Northeast markets, offering both in-person and virtual care. What sets Knownwell apart is clinical depth: the platform is staffed by board-certified obesity medicine physicians — a specialty designation that requires additional training beyond general internal medicine or family practice. That distinction matters in a market where most telehealth platforms assign GLP-1 prescriptions through general practitioners or nurse practitio
Overview
- Consultation Model
- Hybrid
- Headquarters
- Boston, MA
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility.
- Founded
- 2022
Pros
- Board-certified obesity medicine physicians provide a level of clinical specialization not available on most telehealth platforms
- Hybrid model allows in-person examination for complex cases, medication intolerance evaluation, and physical assessment
- Insurance-accepted model reduces out-of-pocket costs compared to cash-pay competitors
- Full GLP-1 formulary including brand-name Wegovy and Zepbound, insulating patients from compounding supply disruptions
- Prior authorization support included
- Appropriate for patients with significant comorbidities (T2D, hypertension, sleep apnea) who need specialist-level management
Cons
- Geographic availability is limited to select Northeast markets; not a national platform as of March 2026
- Insurance-based model means access depends on plan participation and prior authorization approval
- Not the fastest or cheapest path to a GLP-1 prescription for patients who simply want access and have no comorbidities
- In-person visit requirement (when clinically appropriate) is a barrier for patients who cannot travel to a clinic
- Limited public information on cash-pay pricing for patients without covered insurance